DyAnsys, Inc.
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients
Role: lead
Distinguishing Participant Groups Using Autonomic Dysfunction
Role: lead
Cardiac Autonomic Dysfunction and Perioperative Outcomes
Role: collaborator
Neurostimulation an Adjuvant Postoperative Analgesic in Total Knee Replacement (TKR) Surgeries
Role: lead
A Study of New Treatment for Excessive Alcohol Users by Electric Stimulation of Nerves Around Ear
Role: lead
Distinguishing Patient Groups Using Autonomic Dysfunction
Role: lead
Heartrate Variability and Intraoperative Brain Conditions in Supratentorial Tumors
Role: lead
To Study and Evaluate the Effectiveness of Treatment by Percutaneous Electrical NeuroStimulation (PENS) for Post-operative Pain in Cesarean Section Patients Using Primary Relief v 2.0
Role: lead
Percutaneous Electrical Nerve Stimulation (PENS) of the Auricle for Post Operative Pain Solution(POPS) - Cardiac Surgery
Role: lead
First Relief Treatment for Peripheral Neuropathy
Role: lead
ANSiStim Study for Active Labor Pain
Role: lead
All 11 trials loaded